However, anti-metastatic properties of RAS inhibitors were mainly associated with effects on the host microenvironment, including infiltration of tumor-associated macrophages or tumor-related angiogenesis [20], [21], and to date there has been no report on potential metastatic effects of AngII through direct cancer cell activation. This evidence concerns the gene AGT and cancer.